Research Article
Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren
Table 2
General characteristics of components of metabolic syndrome, insulin secretion, and resistance in boys and girls.
| | | Boys | Girls | | | Normal | Overweight | Obese | Normal | Overweight | Obese |
| | 88 | 44 | 40 | 128 | 34 | 27 | | Age (year) | 10.3 ± 1.6 | 11.1 ± 1.3 | 9.7 ± 1.4 | 10.1 ± 1.5 | 10.5 ± 1.4 | 10.3 ± 1.8 | | BMI percentile (%) | 53.5 ± 23.8 | 92.3 ± 2.6 | 97.6 ± 1.1 | 48.3 ± 24.1 | 90.1 ± 2.7 | 97.3 ± 1.2 | | Body fat (%) | 22.2 ± 6.4 | 23.9 ± 3.3 | 27.3 ± 2.8 | 19.7 ± 2.8 | 25.0 ± 2.7 | 28.2 ± 1.9 | | FPG (mmol/L) | 5.07 ± 0.42 | 5.12 ± 0.40 | 5.11 ± 0.43 | 4.93 ± 0.39 | 5.02 ± 0.31 | 4.96 ± 0.36 | | SBP (mmHg) | 113.0 ± 9.0 | 120.9 ± 9.7 | 122.2 ± 11.3 | 115.8 ± 10.2 | 121.2 ± 9.1 | 120.9 ± 9.5 | | DBP (mmHg) | 71.2 ± 7.8 | 73.2 ± 8.3 | 72.5 ± 9.4 | 73.8 ± 9.9 | 71.8 ± 6.2 | 75.2 ± 11.2 | | TG (mg/dL) | 0.62 ± 0.27 | 0.90 ± 0.49 | 0.96 ± 0.57 | 0.73 ± 0.30 | 0.96 ± 0.38 | 1.31 ± 1.59 | | HDL (mg/dL) | 1.47 ± 0.33 | 1.29 ± 0.29 | 1.18 ± 0.27 | 1.42 ± 0.29 | 1.30 ± 0.27 | 1.16 ± 0.33 | | LDL (mg/dL) | 2.54 ± 0.68 | 2.43 ± 0.57 | 2.64 ± 0.59 | 2.40 ± 0.68 | 2.47 ± 0.50 | 2.64 ± 0.55 | | hsCRP | 0.68 ± 1.07 | 0.72 ± 0.84 | 1.58 ± 1.45 | 0.43 ± 0.82 | 1.03 ± 1.35 | 1.17 ± 1.13 | | HOMA-β | 164.4 ± 164.3 | 233.1 ± 178.8 | 253.2 ± 118.2 | 209.9 ± 218.4 | 245.8 ± 214.6 | 362.0 ± 336.5 | | HOMA-IR | 3.09 ± 3.95 | 4.40 ± 5.90 | 4.10 ± 2.35 | 3.34 ± 4.10 | 4.24 ± 3.45 | 6.05 ± 5.37 | | uPA (pg/mL) | 608.6 ± 516.5 | 597.9 ± 468.5 | 614.9 ± 502.8 | 573.8 ± 343.9 | 511.9 ± 324.5 | 888.2 ± 899.9 | | suPAR (pg/mL) | 5509.3 ± 1652.7 | 5737.3 ± 1449.1 | 6546.0 ± 1679.5 | 5558.0 ± 1604.9 | 6021.7 ± 1758.6 | 6606.6 ± 2286.0 | | PAI-1 (ng/mL) | 13.59 ± 8.62 | 17.88 ± 11.12 | 19.43 ± 14.35 | 16.22 ± 8.73 | 17.10 ± 9.21 | 21.01 ± 9.83 |
|
|
Data shown: mean ± SD, uPA: urokinase plasminogen activator, suPAR: soluble urokinase plasminogen activator receptor, PAI-1: plasminogen activator inhibitor-1, BMI: body mass index, FPG: fasting plasma glucose, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: triglyceride, HDL: high-density lipoprotein-cholesterol, LDL: low-density lipoprotein-cholesterol, HOMA-β (insulin secretion): homeostatic model assessment-β, and HOMA-IR (insulin resistance): homeostatic model assessment-insulin resistance; against normal, against overweight, and against obese.
|
